A New Approach for the Detection of Type III Hyperlipoproteinemia by RLP-Cholesterol Assay

Journal of Atherosclerosis and Thrombosis

Volumn 1, Issue 1, 1994, Pages 30-36

  Nakajima, Katsuyuki ^a   Saito, Toshimitsu ^a   Tamura, Aki ^a   Suzuki, Motoko ^a   Nakano, Takamitsu ^a   Adachi, Masakazu ^a   Tanaka, Akira ^b   Tada, Norio ^c   Nakamura, Haruo ^d   Murase, Toshio ^e  

^a JAPAN IMMUNORESEARCH LABORATORIES   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c Jikei University School of Medicine   (Japan)

^d NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^e TORANOMON HOSPITAL   (Japan)

Author keywords

Apo E2 2; Chylomicron remnant; RLPcholesterol; VLDL remnant

Indexed keywords

TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERLIPOPROTEINEMIA TYPE 3; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; MONITORING; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; CHOLESTEROL, VLDL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEASIBILITY STUDIES; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE III; MALE; MASS SCREENING; MIDDLE AGED; MONITORING, PHYSIOLOGIC; TRIGLYCERIDES;

EID: 0028677564     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat1994.1.30     Document Type: Article

References (23)

1. Havel RJ, Goldstein JL, and Brown MS: Lipoproteins and lipid transport. In Metabolic Control and Disease, 8th Ed, ed by Bondy PK and Rosenberg LE, pp 393-494, Saunders WB, Philadelphia, 1980
2. Kane JP, Chen GC, Hamilton RL, Hardman DA, Malloy MJ, and Havel RJ: Remnants of lipoproteins of intestinal and hepatic origin in familial dysbetalipoproteinemia. Arteriosclerosis, 3: 47-56, 1983
3. Havel RJ, Chao Y-S, Windier EE, Kotite L, and Guo LSS: Isoprotein specificity in the hepatic uptake of apoprotein E and the pathogenesis of familial dysbetalipoproteinemia. Proc Natl Acad Sci USA, 77: 4349-4353, 1980
4. Shneider WJ, Kovanen PT, Brown MS, Goldstein JL, Utermann G, Weber W, Havel RJ, Kptite L, Kane JP, Innerarity TL, and Mahley RW: Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits and cow. J Clin Invest, 68: 1075-1085, 1981
5. Utermann G, Vogelberg KH, Steinmetz A, Schoenborn W, Pruin N, Jaeschke M, and Hees M: Polymorphism of apolipoprotein E. II. Genetics of hyperlipoproteinemia type III. Clin Genet, 15: 37-62, 1979
6. Nakajima K, Saito T, Tamura A, Suzuki M, Nakano T, Adachi M, Tanaka A, Tada N, Ishikawa T, and Nakamura H: A new assay method for remnant lipoprotein and its clinical significance. J Jpn Atheroscler Soc, 20: 79-88, 1992
7. Ikewaki K: Postprandial lipemia in patients with coronary artery disease. J Jpn Atheroscler Soc, 18: 887-895, 1990
8. Tada N, Nakajima K, and Nakamura H: Remnant hyperlipoproteinemia. Prog Med, 11: 66-72, 1991
9. Takagi S, Fukuo Y, Seta K, Saito T, Nakajima K, Hasegawa T, Nakajima S, and Terashi A: Particle remnants (RLP, LipoZ) and lipoproteins in patients with chronic cerebral infarction. J Jpn Atheroscler Soc, 20: 675-679, 1992
10. Campos E, Nakajima K, Tanaka A, and Havel RJ: Properties of an apolipoproteins E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100. J Lipid Res, 33: 369-380, 1992
11. Seimetz A: Phenotyping of human apolipoprotein E from whole blood plasma by immunoblotting. J Lipid Res, 28: 1364-1370, 1987
12. Havel RJ, Eder HA, and Bragdon JH: The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest, 34: 1345-1353, 1953
13. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem, 193: 265-275, 1951
14. Hara I and Okazaki M: High-performance liquid chromatography of serum lipoproteins. Method Enzymol, 129: 57-78, 1986
15. Pagnan A, Havel RJ, Kane JP, and Kotite L: Characterization of human very low density lipoproteins containing two electrophoretic populations: double prebeta lipoproteinemia and primary disbetalipoproteinemia. J Lipid Res, 18: 6213-6232, 1977
16. Sata T, Havel RJ, and Jones AL: Characterization of subtractions of triglyceride-rich lipoproteins separated by gel chromatography from blood serum of normolipidemic and hyperlipemic humans. J Lipid Res, 13: 757-768, 1972
17. Havel RJ and Kane JP: Primary dysbetalipoproteinemia. Predominance of a specific apoprotein species in triglyceride lipoproteins. Proc Natl Acad Sci USA, 70: 2015-2019, 1973
18. Fainaru M, Mahley RW, Hamilton RL, and Innerarity T: Structural and metabolic heterogeneity of beta-very low density lipoproteins from cholesterol fed dogs and from humans with Type III hyperlipoproteinemia. J Lipid Res, 23: 702-714, 1982
19. Kane JP, Chen GC, Hamilton RL, Hardman DA, Malloy MJ, and Havel RJ: Remnants of lipoproteins of intestinal and hepatic origin in familial dysbetalipoproteinemia. Arteriosclerosis, 3: 47-56, 1983
20. Nakajima K, Nakano T, Saito T, Tamura A, Suzuki M, Shimoyama M, Tachibana K, Akiba T, and Tanaka A: Effect of heparin (PHLA) on serum remnant like particles in hemodialysis patients. J Jpn Atheroscler Soc, 20: 373, 1992
21. Utermann G, Hees M, and Steinmetz A: Polymorphism of apolipoproteins E and occurance of dysbetalipoproteinemia in man. Nature, 269: 604-607, 1977
22. Morganroth JR, Levy I, and Fredrickson DS: The biochemical, clinical and genetic features of type III hyperlipoproteinemia. Ann Intern Med, 72: 150-165, 1975
23. Mahley RW and Rail SC Jr: Type III hyperlipoproteinemia (dysbetalipoproteinemia): The role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In the Metabolic Basis of Inherited Disease, 6th Ed, ed by Scriver CR, Beaudet AL, Sly WS and Valk D, pp 1195-1213, McGraw-Hill, New York, 1989